Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | EIF2C2 |
| Upstream (Parents) |
|---|
| (<<) DYNC1LI2 → EIF2C2 |
| (<<) GNG11 → EIF2C2 |
| (<<) HIPK1 → EIF2C2 |
| (<<) ITGB5 → EIF2C2 |
| (<<) LRP5 → EIF2C2 |
| (<<) NFAT5 → EIF2C2 |
| (<<) NMNAT1 → EIF2C2 |
| (<<) NOL9 → EIF2C2 |
| (<<) THOC4 → EIF2C2 |
| (<<) UBE2C → EIF2C2 |
| Downstream (Children) |
|---|
| EIF2C2 → ATP2B1 (>>) |
| EIF2C2 → CACNA1I (>>) |
| EIF2C2 → CAMKK1 (>>) |
| EIF2C2 → CASP7 (>>) |
| EIF2C2 → CBL (>>) |
| EIF2C2 → CBS (>>) |
| EIF2C2 → COIL (>>) |
| EIF2C2 → DDX18 (>>) |
| EIF2C2 → EFNB2 (>>) |
| EIF2C2 → EGFR (>>) |
| EIF2C2 → EML4 (>>) |
| EIF2C2 → GNB4 (>>) |
| EIF2C2 → GNG10 (>>) |
| EIF2C2 → GPX2 (>>) |
| EIF2C2 → KLF7 (>>) |
| EIF2C2 → LYAR (>>) |
| EIF2C2 → MAP3K3 (>>) |
| EIF2C2 → PABPC3 (>>) |
| EIF2C2 → PRKCI (>>) |
| EIF2C2 → PTK2 (>>) |
| EIF2C2 → SESN1 (>>) |
| EIF2C2 → SLC25A37 (>>) |
| EIF2C2 → SLC7A5 (>>) |
| EIF2C2 → SOX9 (>>) |
| EIF2C2 → SUMF1 (>>) |
| EIF2C2 → WASF2 (>>) |
